Initial antiretroviral therapy: The dilemmas ahead

被引：0
|
作者：
Arribas, Jose R. [1 ]
机构：
[1] Hosp Univ La Paz, Internal Med Serv, HIV Unit, IdiPAZ, Madrid, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2013年 / 31卷 / 02期
关键词：
CO-FORMULATED ELVITEGRAVIR; NON-INFERIORITY TRIAL; NAIVE ADULTS; DOUBLE-BLIND; HIV-1; INFECTION; TENOFOVIR; PHASE-3; EMTRICITABINE; EFAVIRENZ; RILPIVIRINE;
D O I：
10.1016/j.eimc.2012.07.011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：68 / 70
页数：3
相关论文
共 50 条
  • [31] Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature
    Goulding, Alison N.
    Meeks, Kasey
    Shay, Lena
    Casey, Sarah
    Applegarth, Colton
    Mckinney, Jennifer
    CURRENT HIV/AIDS REPORTS, 2024, 21 (01) : 1 - 10
  • [32] Clinical considerations when switching antiretroviral therapy
    Fernandez, Analuz
    Imaz, Arkaitz
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (07) : 565 - 577
  • [33] Weight Gain in People with HIV: The Role of Demographics, Antiretroviral Therapy, and Lifestyle Factors on Weight
    Patel, Yesha S.
    Doshi, Anjali D.
    Levesque, Anna E.
    Lindor, Shelsie
    Moranville, Robert D.
    Okere, Sheila C.
    Robinson, Danielle B.
    Taylor, Lauren
    Lustberg, Mark E.
    Malvestutto, Carlos D.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2023, 39 (12) : 652 - 661
  • [34] An Update on Antiretroviral Therapy
    Menendez-Arias, Luis
    Martin-Alonso, Samara
    Frutos-Beltran, Estrella
    ANTIVIRAL DRUG DISCOVERY AND DEVELOPMENT, 2021, 1322 : 31 - 61
  • [35] Antiretroviral Therapy in the Clinic
    Tsibris, Athe M. N.
    Hirsch, Martin S.
    JOURNAL OF VIROLOGY, 2010, 84 (11) : 5458 - 5464
  • [36] Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
    Zhao, Ying
    Griesel, Rulan
    Omar, Zaayid
    Simmons, Bryony
    Hill, Andrew
    van Zyl, Gert
    Keene, Claire
    Maartens, Gary
    Meintjes, Graeme
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (10) : 1832 - 1840
  • [37] Neuropsychiatric adverse drug reactions and associated factors in a cohort of individuals starting dolutegravir-based or efavirenz-based antiretroviral therapy in Belo Horizonte, Brazil
    Mendes, Jullye Campos
    Braga, Maria das Gracas
    Reis, Adriano Max Moreira
    Silveira, Micheline Rosa
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (04) : 523 - 531
  • [38] Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus
    Kim, Jeffrey
    Behzadi, Elisa S.
    Nehring, Mary
    Carver, Scott
    Cowan, Shannon R.
    Conry, Megan K.
    Rawlinson, Jennifer E.
    VandeWoude, Sue
    Miller, Craig A.
    VIRUSES-BASEL, 2023, 15 (04):
  • [39] Antiretroviral therapy 2010 update: Current practices and controversies
    Grant, Matthew
    Samuel, Rafik
    Bettiker, Robert L.
    Suh, Byungse
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (07) : 1045 - 1053
  • [40] Trends in antiretroviral therapy prescription, durability and modification: new drugs, more changes, but less failure
    Eaton, Ellen F.
    Tamhane, Ashutosh
    Davy-Mendez, Thibaut
    Mathews, William C.
    Moore, Richard D.
    Saag, Michael S.
    Mugavero, Michael J.
    AIDS, 2018, 32 (03) : 347 - 355
12345